LOVELAND, Colo., Aug. 30, 2018 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a providerof advanced veterinary diagnostic and specialty products, announced that Steve Eyl, Heska's EVP of Global Sales & Marketing, and Jon Aagaard, Director of Investor Relations, will be holding
Heska Corporation (NASDAQ: HSKA - News) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products. Heska's business is composed of Core Companion Animal Health ("CCA") segment, which represents approximately 80% of revenues, and Other Vaccines, Pharmaceuticals and Products ("OVP") segment. CCA segment includes, primarily for canine and feline use, Point of Care Laboratory testing instruments and consumables under a unique multi-year Reset Subscription model, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. OVP segment includes, primarily for herd animal health, private label vaccine and pharmaceutical production under third party agreements and channels. For further information on Heska and its products, visit www.heska.com.
View original content:http://www.prnewswire.com/news-releases/heska-to-hold-one-on-one-meetings-at-cl-kings-16th-annual-best-ideas-conference-2018-on-september-13-2018-300704284.html
SOURCE Heska Corporation
Subscribe to our Free Newsletters!